Education
About Us
Working with TipRanks
Follow Us
Teleflex (TFX)
:TFX
TFX Stock Chart & Stats
$124.75
-$2.38(-1.33%)
At close: 4:00 PM EST
$124.75
-$2.38(-1.33%)
Day’s Range― - ―
52-Week Range$102.58 - $195.24
Previous CloseN/A
Volume73.33K
Average Volume (3M)564.00K
Market Cap
$4.83B
Enterprise Value$7.72B
Total Cash (Recent Filing)$354.00M
Total Debt (Recent Filing)$2.77B
Price to Earnings (P/E)―
Beta0.61
Next Earnings
Feb 19, 2026EPS Estimate
3.84Last Dividend Ex-Date
Nov 14, 2025Dividend Yield1.13%
Share Statistics
EPS (TTM)3.67
Shares Outstanding44,194,410
10 Day Avg. Volume774,323
30 Day Avg. Volume564,003
Financial Highlights & Ratios
PEG Ratio-1.49
Price to Book (P/B)1.95
Price to Sales (P/S)2.74
P/FCF Ratio16.37
Enterprise Value/Market Cap1.60
Enterprise Value/Revenue2.42
Enterprise Value/Gross Profit4.51
Enterprise Value/Ebitda132.90
Forecast
1Y Price Target
$137.50Price Target Upside10.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Business IntegrationThe BioTronik integration is going exceptionally well, with both TFX and BioTronik teams working strongly together and positive energy all around.
International ExpansionManagement anticipates a notable expansion in the combined company's international scale, reducing reliance on the U.S. market and opening the door for broader adoption of TFX products.
Product InnovationStrong feedback from the clinician panel highlighted the superior solution provided by the covered stent to deal with acute coronary artery perforations.
Bears Say
Financial UncertaintyLimited visibility into the post-acquisition, post-spin financials is expected to limit nearer-term share price appreciation.
Margin DeclineTFX's gross margin was down 350 bps year over year and its operating margin was down 400 bps year over year.
Revenue GuidanceManagement lowered their 2025 revenue guidance due to slower intra-aortic balloon pump sales.
Teleflex News
TFX FAQ
What was Teleflex’s price range in the past 12 months?
Teleflex lowest stock price was $102.58 and its highest was $195.24 in the past 12 months.
What is Teleflex’s market cap?
Teleflex’s market cap is $4.83B.
When is Teleflex’s upcoming earnings report date?
Teleflex’s upcoming earnings report date is Feb 19, 2026 which is in 73 days.
How were Teleflex’s earnings last quarter?
Teleflex released its earnings results on Nov 06, 2025. The company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $3.41 by $0.26.
Is Teleflex overvalued?
According to Wall Street analysts Teleflex’s price is currently Undervalued.
Does Teleflex pay dividends?
Teleflex pays a Quarterly dividend of $0.34 which represents an annual dividend yield of 1.13%. See more information on Teleflex dividends here
What is Teleflex’s EPS estimate?
Teleflex’s EPS estimate is 3.84.
How many shares outstanding does Teleflex have?
Teleflex has 44,194,410 shares outstanding.
What happened to Teleflex’s price movement after its last earnings report?
Teleflex reported an EPS of $3.67 in its last earnings report, beating expectations of $3.41. Following the earnings report the stock price went down -13.019%.
Which hedge fund is a major shareholder of Teleflex?
Currently, no hedge funds are holding shares in TFX
Teleflex Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$137.50 (10.22% Upside)
$137.50 (10.22% Upside)
Blogger Sentiment
Bullish
TFX Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 192.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $633.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 3.2%
Last 30 Days ▼ 12.3%
Last 30 Days ▼ 12.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.21%
12-Months-Change
Fundamentals
Return on Equity
-7.90%
Trailing 12-Months
Asset Growth
5.15%
Trailing 12-Months
Company Description
Teleflex
Teleflex Incorporated (NYSE: TFX) is a global provider of medical technologies designed to enhance the health and quality of life of patients. The company operates in various sectors, including vascular access, anesthesia, respiratory care, urology, and surgical instruments. Teleflex offers a diverse range of products, including catheters, surgical devices, and specialty tools that address various medical needs, aiming to improve patient outcomes and streamline healthcare processes.
TFX Company Deck
TFX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. The company showed strong revenue growth and successful integration of acquisitions, but faced challenges with specific product lines and regions, impacting margins and necessitating a reduction in revenue guidance. The overall sentiment is balanced with notable strengths and weaknesses.View all TFX earnings summariesTFX Stock 12 Month Forecast
Average Price Target
$137.50
▲(10.22% Upside)
Technical Analysis
Haemonetics
―
ICU Medical
―
Lemaitre Vascular
―
Merit Medical Systems
―
Bausch + Lomb Corporation
―
Ownership Overview
0.42% Insiders
41.28% Mutual Funds
27.58% Other Institutional Investors
8.28% Public Companies and
Individual Investors